Paediatric Hidradenitis Suppurativa: Successful Treatment With Bimekizumab and Multidimensional Impact on Quality of Life
This case report describes the successful treatment of a 15-year-old male with severe hidradenitis suppurativa (HS) using bimekizumab. The patient, previously unresponsive to adalimumab, showed significant clinical and psychological improvement after 6 months of treatment, highlighting the potential of bimekizumab as a therapeutic option for paediatric HS.
Authors
- Giammarco Granieri (ORCID: https://orcid.org/0000-0002-6788-3253)
- Alessandra Michelucci (ORCID: https://orcid.org/0000-0002-0795-0338)
- Flavia Manzo Margiotta (ORCID: https://orcid.org/0000-0002-9593-9357)
- Bianca Cei (ORCID: https://orcid.org/0000-0002-9092-7795)
- Marco ROMANELLI
- Valentina Dini
Institutions
- University of Pisa (IT)
- Scuola Superiore Sant'Anna (IT)
Publication Details
- Journal
- Australasian Journal of Dermatology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1111/ajd.70049
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00